Related references
Note: Only part of the references are listed.Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma
Shuting Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Significance of alternative splicing in cancer cells
Fei Qi et al.
CHINESE MEDICAL JOURNAL (2020)
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment
Fa-Peng Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Yap suppresses T-cell function and infiltration in the tumor microenvironment
Eleni Stampouloglou et al.
PLOS BIOLOGY (2020)
Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor Phenotype
Lea Paolini et al.
CANCER IMMUNOLOGY RESEARCH (2020)
MicroRNA-802 Inhibits Cell Proliferation and Induces Apoptosis in Human Laryngeal Cancer by Targeting cAMP-Regulated Phosphoprotein 19
Huafu Ye et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma
Feng Xue et al.
PEERJ (2020)
Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance
Yongfu Xiong et al.
FRONTIERS IN GENETICS (2020)
Alternative Splicing in Hepatocellular Carcinoma
Seung Eun Lee et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine
Deepak Kanojia et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial
Thomas Yau et al.
JAMA ONCOLOGY (2020)
Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic Significance
Wenbiao Chen et al.
FRONTIERS IN ONCOLOGY (2020)
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer
Ledong Wan et al.
GUT (2019)
Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment
Jianbo Feng et al.
ONCOGENE (2019)
The expanding landscape of 'oncohistone' mutations in human cancers
Benjamin A. Nacev et al.
NATURE (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Loss of FGL1 induces epithelial-mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma
Fenglong Bie et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Systematic profiling of alternative splicing events and splicing factors in left- and right-sided colon cancer
Xiaoliang Huang et al.
AGING-US (2019)
TNIP1 Inhibits Proliferation And Promotes Apoptosis In Clear Cell Renal Carcinoma Through Targeting C/Ebpβ
Yong Yang et al.
ONCOTARGETS AND THERAPY (2019)
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas
Lingpeng Yang et al.
PEERJ (2019)
Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment
Zhi-Xuan Li et al.
THERANOSTICS (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer
Hao Yuan et al.
CANCER LETTERS (2018)
The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
Helena J. Janse van Rensburg et al.
CANCER RESEARCH (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
Yutaka Kurebayashi et al.
HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer
Jingwei Liu et al.
JOURNAL OF CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication
Naoshi Nishida et al.
ONCOLOGY (2017)
Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy
Maryam Tahmasebi Birgani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies
David J. Byun et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
The Functional Impact of Alternative Splicing in Cancer
Hector Climente-Gonzalez et al.
CELL REPORTS (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
UpSetR: an R package for the visualization of intersecting sets and their properties
Jake R. Conway et al.
BIOINFORMATICS (2017)
Tumor microenvironment and therapeutic response
Ting Wu et al.
CANCER LETTERS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Guocan Wang et al.
CANCER DISCOVERY (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity
Jun Yao et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
The human splicing code reveals new insights into the genetic determinants of disease
Hui Y. Xiong et al.
SCIENCE (2015)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
SpliceSeq: a resource for analysis and visualization of RNA-Seq data on alternative splicing and its functional impacts
Michael C. Ryan et al.
BIOINFORMATICS (2012)
Immunotherapy of cancer in 2012
John M. Kirkwood et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
MiR-185 Targets the DNA Methyltransferases 1 and Regulates Global DNA Methylation in human glioma
Zuping Zhang et al.
MOLECULAR CANCER (2011)
Sparse kernel learning with LASSO and Bayesian inference algorithm
Junbin Gao et al.
NEURAL NETWORKS (2010)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
